SCHEMBL27788293

SCHEMBL27788293

Cc1cc(-c2nnc(C(S)c3noc(-c4cccc(Cl)c4)n3)n2C)ccn1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 2/20 0.54
GRM5 P41594 5/20 0.49
GRM2 Q14416 1/20 0.41
NPC1 O15118 6/20 0.40
MAPT P10636 4/20 0.40
RAB9A P51151 4/20 0.40
TSHR P16473 3/20 0.40
TP53 P04637 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
MITF O75030 1/20 0.40
PKM P14618 1/20 0.40
S1PR1 P21453 2/20 0.37
PIM1 P11309 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
S1PR3 Q99500 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1544327 1.00 KCNH2 (0.54) KCNH2GRM5GRM2NPC1MAPT
SCHEMBL1544042 0.92 KCNH2 (0.56) KCNH2GRM5NPC1MAPTRAB9A
SCHEMBL27810140 0.89 KCNH2 (0.67) KCNH2GRM5NPC1MAPTRAB9A
SCHEMBL1543750 0.89 KCNH2 (0.46) KCNH2GRM5NPC1MAPTRAB9A
SCHEMBL1543857 0.89 KCNH2 (0.42) KCNH2GRM5NPC1RAB9ATP53
SCHEMBL1544139 0.87 KCNH2 (0.56) KCNH2GRM5NPC1MAPTRAB9A
SCHEMBL1544376 0.87 KCNH2 (0.52) KCNH2GRM5NPC1MAPTRAB9A
SCHEMBL27810210 0.86 KCNH2 (0.55) KCNH2GRM5NPC1MAPTRAB9A
SCHEMBL1544614 0.86 KCNH2 (0.51) KCNH2GRM5NPC1MAPTRAB9A
SCHEMBL1544101 0.85 KCNH2 (0.52) KCNH2GRM5NPC1MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101723941-A “1,2,4” oxadiazole as a metabotropic glutamate receptor-5 modulator ASTRAZENECA AB 2010-06-09 CN claimed
CN-101723941-A “1,2,4” oxadiazole as a metabotropic glutamate receptor-5 modulator ASTRAZENECA AB 2010-06-09 CN disclosed